This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Jean-Marc Groell
Introduction
Jean-Marc Groell is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target critical interactions in cellular processes.
Latest Patents
Jean-Marc Groell holds a patent for "3-imidazolyl-indoles for the treatment of proliferative diseases." This invention relates to 3-heterocyclyl indolyl compounds capable of inhibiting the interaction between p53 and MDM2 and/or MDM4. The compounds are designed to be useful in treating various disorders and diseases mediated by the activity of MDM2 and/or MDM4, including inflammatory or proliferative diseases.
Career Highlights
Jean-Marc Groell is associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions for complex medical challenges, contributing to advancements in therapeutic options.
Collaborations
He has collaborated with notable colleagues such as Andreas Boettcher and Nicole Buschmann, enhancing the research and development efforts within his field.
Conclusion
Jean-Marc Groell's contributions to medicinal chemistry and his innovative patent highlight his role as a significant inventor in the treatment of proliferative diseases. His work continues to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile